ArticleCancer science2021

Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.

Makoto Sumitomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.